Familial hypercholesterolemia (FH) is a genetic disease characterized by high low-density
lipoprotein (LDL) cholesterol (LDL-c) concentrations that increase cardiovascular risk and …

Abstract Background and Aims Familial hypercholesterolaemia (FH) is a highly prevalent
monogenic disorder characterized by elevated LDL cholesterol (LDL-C) levels and …

Aims The aim of this study was to assess the impact and cost-effectiveness of offering
population genomic screening to all young adults in Australia to detect heterozygous familial …

Background Heterozygous familial hypercholesterolemia (HeFH) is a genetic disorder
characterized by elevated levels of low-density lipoprotein cholesterol (LDL-C). Objective …

In 1964, the clinical heterozygous and homozygous forms of the disease were described 3
and in 1973 Brown and Goldstein showed that FH was caused by defects in the gene coding …

Familial hypercholesterolemia (FH) is a hereditary disorder that causes severely elevated
low-density lipoprotein (LDL-C) levels, which leads to an increased risk for premature …

Although great progress has been made in the diagnostic and treatment options for
dyslipidemias, unawareness, underdiagnosis and undertreatment of these disorders remain …

Background Familial hypercholesterolaemia (FH) is a genetic condition characterised by
elevated levels of low-density lipoprotein cholesterol (LDL-C) and an increased risk of …

Introduction Familial hypercholesterolemia (FH) is a frequent genetic disorder characterized
by elevated LDL-cholesterol (LDL-C) and early onset of atherosclerosis. Areas covered The …

Cardiovascular disease (CVD) has been a burden to many developing countries for
decades, including Malaysia. Although various steps have been taken to prevent and …